PortalPublikationenPeripheral neuropathy associated with subcutaneous or intrav...

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial

Standard

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial. / Merz, Maximilian; Salwender, Hans; Haenel, Mathias; Mai, Elias K; Bertsch, Uta; Kunz, Christina; Hielscher, Thomas; Blau, Igor W; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Hillengass, Jens; Raab, Marc S; Schurich, Baerbel; Munder, Markus; Brossart, Peter; Gerecke, Christian; Lindemann, Hans-Walter; Zeis, Matthias; Weisel, Katja; Duerig, Jan; Goldschmidt, Hartmut.

in: HAEMATOLOGICA, Jahrgang 101, Nr. 12, 12.2016, S. e485-e487.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Merz, M, Salwender, H, Haenel, M, Mai, EK, Bertsch, U, Kunz, C, Hielscher, T, Blau, IW, Scheid, C, Hose, D, Seckinger, A, Jauch, A, Hillengass, J, Raab, MS, Schurich, B, Munder, M, Brossart, P, Gerecke, C, Lindemann, H-W, Zeis, M, Weisel, K, Duerig, J & Goldschmidt, H 2016, 'Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial', HAEMATOLOGICA, Jg. 101, Nr. 12, S. e485-e487. https://doi.org/10.3324/haematol.2016.151266

APA

Merz, M., Salwender, H., Haenel, M., Mai, E. K., Bertsch, U., Kunz, C., Hielscher, T., Blau, I. W., Scheid, C., Hose, D., Seckinger, A., Jauch, A., Hillengass, J., Raab, M. S., Schurich, B., Munder, M., Brossart, P., Gerecke, C., Lindemann, H-W., ... Goldschmidt, H. (2016). Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial. HAEMATOLOGICA, 101(12), e485-e487. https://doi.org/10.3324/haematol.2016.151266

Vancouver

Merz M, Salwender H, Haenel M, Mai EK, Bertsch U, Kunz C et al. Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial. HAEMATOLOGICA. 2016 Dez;101(12):e485-e487. https://doi.org/10.3324/haematol.2016.151266

Bibtex

@article{270a3622db444de99dfca4c83cc64709,
title = "Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial",
keywords = "Antineoplastic Agents, Bortezomib, Humans, Induction Chemotherapy, Multiple Myeloma, Peripheral Nervous System Diseases, Risk Factors, Clinical Trial, Phase III, Letter, Research Support, Non-U.S. Gov't",
author = "Maximilian Merz and Hans Salwender and Mathias Haenel and Mai, {Elias K} and Uta Bertsch and Christina Kunz and Thomas Hielscher and Blau, {Igor W} and Christof Scheid and Dirk Hose and Anja Seckinger and Anna Jauch and Jens Hillengass and Raab, {Marc S} and Baerbel Schurich and Markus Munder and Peter Brossart and Christian Gerecke and Hans-Walter Lindemann and Matthias Zeis and Katja Weisel and Jan Duerig and Hartmut Goldschmidt",
year = "2016",
month = dec,
doi = "10.3324/haematol.2016.151266",
language = "English",
volume = "101",
pages = "e485--e487",
journal = "HAEMATOLOGICA",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "12",

}

RIS

TY - JOUR

T1 - Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial

AU - Merz, Maximilian

AU - Salwender, Hans

AU - Haenel, Mathias

AU - Mai, Elias K

AU - Bertsch, Uta

AU - Kunz, Christina

AU - Hielscher, Thomas

AU - Blau, Igor W

AU - Scheid, Christof

AU - Hose, Dirk

AU - Seckinger, Anja

AU - Jauch, Anna

AU - Hillengass, Jens

AU - Raab, Marc S

AU - Schurich, Baerbel

AU - Munder, Markus

AU - Brossart, Peter

AU - Gerecke, Christian

AU - Lindemann, Hans-Walter

AU - Zeis, Matthias

AU - Weisel, Katja

AU - Duerig, Jan

AU - Goldschmidt, Hartmut

PY - 2016/12

Y1 - 2016/12

KW - Antineoplastic Agents

KW - Bortezomib

KW - Humans

KW - Induction Chemotherapy

KW - Multiple Myeloma

KW - Peripheral Nervous System Diseases

KW - Risk Factors

KW - Clinical Trial, Phase III

KW - Letter

KW - Research Support, Non-U.S. Gov't

U2 - 10.3324/haematol.2016.151266

DO - 10.3324/haematol.2016.151266

M3 - SCORING: Journal article

C2 - 27540135

VL - 101

SP - e485-e487

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

SN - 0390-6078

IS - 12

ER -